MARKET

OBIO

OBIO

Orchestra BioMed Holdings Inc
NASDAQ
15.54
+3.36
+27.59%
After Hours: 16.14 +0.6 +3.86% 18:19 03/20 EDT
OPEN
11.95
PREV CLOSE
12.18
HIGH
15.80
LOW
11.95
VOLUME
125.99K
TURNOVER
0
52 WEEK HIGH
19.18
52 WEEK LOW
7.49
MARKET CAP
491.28M
P/E (TTM)
-83.7736
1D
5D
1M
3M
1Y
5Y
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 3d ago
Orchestra BioMed Holdings (OBIO) Investor Presentation - Slideshow
Seeking Alpha · 4d ago
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN) and Orchestra BioMed Holdings (OBIO)
TipRanks · 03/08 19:50
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 03/07 13:06
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 03/06 21:31
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
Benzinga · 02/24 15:00
Piper Sandler Initiates Coverage On Orchestra BioMed Hldgs with Overweight Rating, Announces Price Target of $15
Benzinga · 02/24 13:51
--Piper Sandler Starts Orchestra BioMed Holdings at Overweight With $15 Price Target
--Piper Sandler Starts Orchestra BioMed Holdings at Overweight With $15 Price Target
MT Newswires · 02/24 11:31
More
About OBIO
Orchestra BioMed Holdings, Inc. is a biomedical company. It is engaged in developing technologies for patients through risk-reward sharing partnerships with medical device companies. Its flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) and Virtue Sirolimus AngioInfusion Balloon (SAB). BackBeat CNT is a bioelectronic treatment for hypertension that is designed to drive an immediate reduction in blood pressure while simultaneously modulating autonomic nervous system responses to maintain the reduction. Virtue SAB is a patented drug/device combination product candidate in development for the treatment of certain forms of artery disease that is designed to deliver an investigational, extended-release formulation of sirolimus, SirolimusEFR, to the vessel wall during balloon angioplasty without any coating on the balloon surface or the need to leave a stent or other permanent implant in the artery.

Webull offers kinds of Orchestra Biomed Holdings Inc stock information, including NASDAQ:OBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OBIO stock methods without spending real money on the virtual paper trading platform.